Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

GenSight Biologics S.A. - Filing #5982864

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
152,000 EUR
33,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
5 413 EUR
2,603,000 EUR
Current assets
5 343 EUR
6,529,000 EUR
Non-current liabilities
15 058 EUR
14,543,000 EUR
Current liabilities
22 618 EUR
25,290,000 EUR
Revenue
1 500 EUR
1,267,000 EUR
Profit (loss)
14 001 EUR
14 001 EUR
26,220,000 EUR
26,220,000 EUR
Comprehensive income
14 172 EUR
14 001 EUR
171,000 EUR
26,111,000 EUR
26,220,000 EUR
109,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.